Novavax, Inc (NVAX): A Great Stock For Handling Current Market Conditions?

Currently, there are 160.42M common shares owned by the public and among those 146.57M shares have been available to trade. The company’s stock has a 5-day price change of 11.17% and -27.66% over the past three months. NVAX shares are trading -17.04% year to date (YTD), with the 12-month market performance up to 59.19% higher. […]

Technical Outlook And Game Plan For Novavax, Inc (NASDAQ: NVAX)

Novavax, Inc (NVAX) concluded trading on Wednesday at a closing price of $7.47, with 14.72 million shares of worth about $109.93 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.62% during that period and on April 23, 2025 the price saw a gain […]

Why Should You Put Novavax, Inc (NASDAQ: NVAX) On Your Portfolio?

Currently, there are 160.42M common shares owned by the public and among those 146.57M shares have been available to trade. The company’s stock has a 5-day price change of 1.27% and -24.87% over the past three months. NVAX shares are trading -20.52% year to date (YTD), with the 12-month market performance up to 49.30% higher. […]

Some Investing Thoughts On Novavax, Inc (NASDAQ: NVAX)

Novavax, Inc (NVAX) concluded trading on Thursday at a closing price of $5.43, with 22.43 million shares of worth about $121.81 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -58.36% during that period and on April 10, 2025 the price saw a loss […]

Gains May Be On The Menu For Novavax, Inc (NASDAQ: NVAX)

Currently, there are 160.42M common shares owned by the public and among those 146.57M shares have been available to trade. The company’s stock has a 5-day price change of -20.63% and -27.54% over the past three months. NVAX shares are trading -25.37% year to date (YTD), with the 12-month market performance up to 25.52% higher. […]

Novavax, Inc (NASDAQ: NVAX) Stock In Prove Me State

Novavax, Inc (NVAX) concluded trading on Thursday at a closing price of $7.26, with 2.6 million shares of worth about $18.88 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -45.37% during that period and on March 27, 2025 the price saw a loss […]

Novavax, Inc (NVAX) Testing Investors’ Patience Right Now

Currently, there are 160.42M common shares owned by the public and among those 146.57M shares have been available to trade. The company’s stock has a 5-day price change of 0.38% and -11.86% over the past three months. NVAX shares are trading -1.12% year to date (YTD), with the 12-month market performance up to 59.64% higher. […]

Novavax, Inc. (NASDAQ: NVAX) Seen Running Too Hot, Let’s Look At This More Closely

Currently, there are 118.79M common shares owned by the public and among those 111.93M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]

An Important Check-Up On Novavax, Inc. (NASDAQ: NVAX)

Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $3.98, with 4.81 million shares of worth about $19.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -50.68% during that period and on Wednesday the price saw a loss of about […]

Novavax, Inc. (NASDAQ: NVAX) Has Another Chance To Impress You

Currently, there are 118.79M common shares owned by the public and among those 111.93M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]